MedTrace Logo

Plan for Testing Fingerstick Bloods on Magellan Systems

NCT03256383 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 190

Last updated 2017-08-22

No results posted yet for this study

Summary

This study is to supplement our internal data that demonstrates the continued performance of capillary blood samples on Magellan's lead testing systems: LeadCare II, LeadCare Ultra (which have been cleared previously by FDA), and PediaStat, which is an upgraded LeadCare II instrument in development.

Conditions

  • Lead Poisoning

Interventions

DEVICE

Lead testing

Fingerstick

Sponsors & Collaborators

  • Magellan Diagnostics

    lead INDUSTRY

Principal Investigators

  • Peter Rappo, MD

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-31
Primary Completion
2017-08-31
Completion
2017-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03256383 on ClinicalTrials.gov